首页> 美国卫生研究院文献>Oncotarget >Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
【2h】

Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer

机译:骨髓来源的抑制细胞产生的前列腺素E2诱导宫颈癌的癌干细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myeloid-derived suppressor cells (MDSCs) enhance tumor progression by suppressing tumor-specific T cell responses, stimulating tumor angiogenesis, or promoting tumor cell metastasis. However, the biology of MDSCs have not been fully investigated. In the current study, we investigated the role of MDSCs in inducing cancer stem-like cells and explored a clinically feasible approach for targeting MDSCs-mediated cancer stem-like cells induction. In vitro and in vivo experiments revealed that MDSCs induced by tumor-derived G-CSF enhanced the stemness of cervical cancer cells by producing Prostaglandin E2 (PGE2). We also demonstrated that anti-Gr-1 neutralizing antibody or celecoxib inhibited the induction of cancer stem-like cells and enhanced the efficacy of cisplatin in cervical cancer. In clinical samples, MDSCs, PGE2, and CSCs had positive correlations. In conclusion, G-CSF-induced MDSCs enhance the stemness of uterine cervical cancer cells by producing PGE2. Targeting MDSCs or PGE2 might be a reasonable strategy for enhancing the efficacies of treatments. 
机译:髓样来源的抑制细胞(MDSC)通过抑制肿瘤特异性T细胞应答,刺激肿瘤血管生成或促进肿瘤细胞转移来增强肿瘤进展。但是,MDSCs的生物学尚未得到充分研究。在当前的研究中,我们调查了MDSCs在诱导癌症干细胞样细胞中的作用,并探索了针对MDSCs介导的癌症干细胞样细胞诱导的临床可行方法。体外和体内实验表明,由肿瘤来源的G-CSF诱导的MDSC通过产生前列腺素E2(PGE2)增强宫颈癌细胞的干性。我们还证明了抗Gr-1中和抗体或celecoxib抑制了癌干样细胞的诱导并增强了顺铂在宫颈癌中的疗效。在临床样本中,MDSC,PGE2和CSC呈正相关。总之,G-CSF诱导的MDSC通过产生PGE2增强子宫宫颈癌细胞的干性。靶向MDSC或PGE2可能是提高治疗效果的合理策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号